Cheapest Tirzepatide Online in 2026: Verified Prices at Every Dose

Ranked by twelve-month cost

Every row below assumes the escalation most people actually follow: four weeks at 2.5 mg, four weeks at 5 mg, then ten months at 10 mg. That is the shape of a first year on tirzepatide, and it is the only fair way to compare a flat-rate program against a dose-scaled one.

Full price grid

Every tracked program at every dose tier. Membership fees are already added in. Where a program publishes a prepaid rate, we show the month-to-month figure here and note the prepaid discount on the provider page.

Why the cheapest advertised price is usually not the cheapest

Four structures inflate the real number, and all four are legal and disclosed somewhere in the terms:

Dose-scaled pricing. The advertised figure applies to 2.5 mg — a dose you occupy for four weeks. Your prescriber escalates because that is what produces results, and the invoice follows. By 10 mg some programs have more than doubled.

Membership stacking. A competitive medication price plus a separate recurring platform or coaching fee. A $199 medication with a $79 membership is a $278 program. We add these automatically.

Introductory rates that revert. A low first-cycle price that returns to standard at renewal. Ask specifically whether the quoted rate holds through the full commitment.

Unbundled fees. Consultation, shipping, lab work or dose-change charges billed separately. Most tracked programs quote all-in; not all do.

Why nothing legitimate costs under about $99

Active pharmaceutical ingredient, sterile compounding under USP standards, potency and sterility testing, refrigerated shipping and a prescriber's time all have real costs. Below roughly $99 per month, something in that chain is being skipped. The usual candidate is the provenance of the active ingredient.

Products advertised as "research use only" are not manufactured to pharmaceutical standards and are not legal to sell for human use. See our counterfeit guide for the full set of tells.

The FDA-approved options, for comparison

• LillyDirect self-pay Zepbound vials — $299/mo at 2.5 mg, $399 at 5 mg, $449 at 7.5 mg and above with a refill inside 45 days. No subscription; each fill is its own order.
• Zepbound Savings Card — as low as $25/mo, but only with commercial insurance that covers Zepbound for weight management. Unavailable on Medicare or Medicaid by federal law.
• Mounjaro Savings Card — same molecule, $25/mo with commercial insurance and a type 2 diabetes diagnosis.
• Medicare GLP-1 Bridge — $50/mo since 1 July 2026 for eligible Part D enrollees who meet the BMI and comorbidity tiers.
• Retail Zepbound — around $1,089/mo with no program applied.

Before you pay, get these in writing

1. The monthly price at 10 mg and at 15 mg — not the starter price.
2. Whether any membership, consultation, shipping or dose-change fee applies.
3. Whether the quoted rate holds at renewal.
4. Which pharmacy compounds your medication, by name.
5. What happens if a cold-chain shipment arrives warm.
6. Refund terms if you stop after one month of a prepaid plan.

Frequently asked questions

Cheapest program that will tell you which pharmacy fills your prescription

The cheapest programs in the table above mostly will not name the pharmacy that compounds your medication. That is the single most useful thing a program can disclose, because it is the one fact that lets you check a state board register yourself before you inject anything weekly. Fewer than a fifth of the priced programs we track publish it.

Ranked among only those that do, the order looks different — and the cheapest option changes.

This is not a safety rating. A program can name six pharmacies and ship late; another can name none and run a careful operation. What naming buys you is the ability to verify, which matters most in the market where verification is hardest.

The same ranking using only verified prices

Most rankings in this market — including the one above — mix figures of very different quality. Some come from a provider's own published pricing; most come from third-party reviews nobody re-checked. Every time we have verified one of those third-party figures at source, the number moved, and usually upward.

So here is the ranking restricted to prices we read at the provider, the manufacturer, or a named editorial source with a stated verification date. It is a shorter table and a more honest one. If a program you are considering is missing from it, that is not a criticism of the program — it means we have not confirmed its price yet, and you should confirm it yourself before enrolling.

Cheapest tirzepatide on a prepaid twelve-month commitment

The ranking above is month-to-month, which is the right basis if you want to keep the option to stop. It is not the right basis if you already know you will be treating for a year. Several programs publish a lower rate for prepaying a term, and the order changes when you rank on that instead — so here is the same market on the other basis.

Read this table with the commitment in view. A prepaid term is money you generally cannot recover once medication ships, and it is the wrong structure during titration when the main reason to stop is a tolerance problem you have not met yet. It is a reasonable structure once you have held a maintenance dose for a cycle. Only programs that publish a prepaid rate appear here; the rest have nothing to rank.

Two of the entries above are verified against the provider's own published pricing; the rest carry third-party figures we have not confirmed. The badge in the final column says which is which, and the dataset carries the level per record.